Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

We aimed to examine the association of serum 25(OH)D concentration measured in the first and/or in the second halves of pregnancy with the development of GDM in Russian women surveyed before and after the implementation of the guideline on vitamin D deficiency prevention.

Source: 1. Introduction. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Multiple reported designs.

Multiple reported designs

More than one design is explicitly reported; examine the supporting methods.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Vitamin D Status and Gestational Diabetes in Russian Pregnant Women in the Period between 2012 and 2021: A Nested Case: Control Study

Source: Article title.

The women were under observation at ObGyn clinics № 22 (including four ObGyn clinics) in terms of routine medical care.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D Status and Gestational Diabetes in Russian Pregnant Women in the Period between 2012 and 2021: A Nested Case-Control Study

Multiple reported designs · Nutrients · 2022

Original publication title

Vitamin D Status and Gestational Diabetes in Russian Pregnant Women in the Period between 2012 and 2021: A Nested Case: Control Study

Aleksandra S. Tkachuk; Elena A. Vasukova; Anna D. Anopova; Tatiana L. Karonova; Evgenii A. Pustozerov; Yana A. Teplova; Angelina I. Eriskovskaya; Artem O. Isakov; Elena Y. Vasilieva; Maria A. Kokina; Irina Y. Zazerskaya; Tatiana M. Pervunina; Elena N. Grineva; Polina V. Popova

© 2022 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Several meta-analyses found an association between low maternal serum 25-hydroxyvitamin D (25(OH)D) level and gestational diabetes mellitus (GDM). However, some of them reported significant heterogeneity. We examined the association of serum 25(OH)D concentration measured in the first and in the second halves of pregnancy with the development of GDM in Russian women surveyed in the periods of 2012 to 2014 and 2018 to 2021. We conducted a case: control study (including 318 pregnant women) nested on two previous studies. In 2012 to 2014, a total of 214 women (83 GDM and 131 controls) were enrolled before 15 weeks of gestation and maternal serum 25(OH)D concentrations were measured twice: at 8th: 14th week of gestation and simultaneously with two-hour 75 g oral glucose tolerance test (OGTT) at 24th: 32nd week of gestation.

In the period of 2018 to 2021, 104 women (56 GDM and 48 controls) were included after OGTT and 25(OH)D concentrations were measured at 24th: 32nd week of gestation. Median 25(OH)D levels were 20.0 [15.1 to 25.7] vs. 20.5 [14.5 to 27.5] ng/mL (p = 0.565) in GDM and control group in the first half of pregnancy and 25.3 [19.8 to 33.0] vs. 26.7 [20.8 to 36.8] ng/mL (p = 0.471) in the second half of pregnancy, respectively. The prevalence rates for vitamin D deficiency (25(OH)D levels < 20 ng/mL) were 49.4% and 45.8% (p = 0.608) in the first half of pregnancy and 26.2% vs. 22.1% (p = 0.516) in the second half of pregnancy in women who developed GDM and in women without GDM, respectively.

The frequency of vitamin D supplements intake during pregnancy increased in 2018 to 2021 compared to 2012 to 2014 (p = 0.001). However, the third trimester 25(OH)D levels and prevalence of vitamin D deficiency (25.5 vs. 23.1, p = 0.744) did not differ in women examined in the periods of 2012 to 2014 and 2018 to 2021. To conclude, there was no association between gestational diabetes risk and maternal 25(OH)D measured both in the first and in the second halves of pregnancy. The increased prevalence of vitamin D supplements intake during pregnancy by 2018 to 2021 did not lead to higher levels of 25(OH)D.

Authors’ abstract

Several meta-analyses found an association between low maternal serum 25-hydroxyvitamin D (25(OH)D) level and gestational diabetes mellitus (GDM). However, some of them reported significant heterogeneity. We examined the association of serum 25(OH)D concentration measured in the first and in the second halves of pregnancy with the development of GDM in Russian women surveyed in the periods of 2012 to 2014 and 2018 to 2021. We conducted a case: control study (including 318 pregnant women) nested on two previous studies. In 2012 to 2014, a total of 214 women (83 GDM and 131 controls) were enrolled before 15 weeks of gestation and maternal serum 25(OH)D concentrations were measured twice: at 8th: 14th week of gestation and simultaneously with two-hour 75 g oral glucose tolerance test (OGTT) at 24th: 32nd week of gestation.

In the period of 2018 to 2021, 104 women (56 GDM and 48 controls) were included after OGTT and 25(OH)D concentrations were measured at 24th: 32nd week of gestation. Median 25(OH)D levels were 20.0 [15.1 to 25.7] vs. 20.5 [14.5 to 27.5] ng/mL (p = 0.565) in GDM and control group in the first half of pregnancy and 25.3 [19.8 to 33.0] vs. 26.7 [20.8 to 36.8] ng/mL (p = 0.471) in the second half of pregnancy, respectively. The prevalence rates for vitamin D deficiency (25(OH)D levels < 20 ng/mL) were 49.4% and 45.8% (p = 0.608) in the first half of pregnancy and 26.2% vs. 22.1% (p = 0.516) in the second half of pregnancy in women who developed GDM and in women without GDM, respectively.

The frequency of vitamin D supplements intake during pregnancy increased in 2018 to 2021 compared to 2012 to 2014 (p = 0.001). However, the third trimester 25(OH)D levels and prevalence of vitamin D deficiency (25.5 vs. 23.1, p = 0.744) did not differ in women examined in the periods of 2012 to 2014 and 2018 to 2021. To conclude, there was no association between gestational diabetes risk and maternal 25(OH)D measured both in the first and in the second halves of pregnancy. The increased prevalence of vitamin D supplements intake during pregnancy by 2018 to 2021 did not lead to higher levels of 25(OH)D.

Publication and source details

Original title: Vitamin D Status and Gestational Diabetes in Russian Pregnant Women in the Period between 2012 and 2021: A Nested Case: Control Study

Aleksandra S. Tkachuk; Elena A. Vasukova; Anna D. Anopova; Tatiana L. Karonova; Evgenii A. Pustozerov; Yana A. Teplova; Angelina I. Eriskovskaya; Artem O. Isakov; Elena Y. Vasilieva; Maria A. Kokina; Irina Y. Zazerskaya; Tatiana M. Pervunina; Elena N. Grineva; Polina V. Popova

Nutrients · 2022

* Correspondence: pvpopova5@gmail.com© 2022 by the authors.2022https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).Science and Higher Education of the Russian Federation075-15-2022-301This work was financially supported by the Ministry of Science and Higher Education of the Russian Federation (Agreement No. 075-15-2022-301).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T10:09:16.751276+00:00

DOI: 10.3390/nu14102157 · PMC9143366